HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Clodfelder-Miller, B. J. Articles by Jope, R. S. Search for Related Content PubMed PubMed Citation Articles by Clodfelder-Miller, B. J. Articles by Jope, R. S. Social Bookmarking                What's this?

Tau Is Hyperphosphorylated at Multiple Sites in Mouse Brain In Vivo After Streptozotocin-Induced Insulin Deficiency

Department of Psychiatry and Behavioral Neurobiology, University of Alabama, Birmingham, Alabama

Address correspondence and reprint requests to Dr. Richard Jope, Department of Psychiatry and Behavioral Neurobiology, 1720 Seventh Ave. South, Sparks Center 1057, University of Alabama, Birmingham, AL 35294-0017. E-mail: jope{at}uab.edu

Abbreviations: Cdk5, cyclin-dependent kinase-5; ERK1/2, extracellular signal–regulated kinases 1 and 2; GSK, glycogen synthase kinase; JNK, c-Jun N-terminal kinase; PP2A, protein phosphatase 2A; PP2B, protein phosphatase 2B

Deficient signaling by insulin, as occurs in diabetes, is associated with impaired brain function, and diabetes is associated with an increased prevalence of Alzheimer’s disease. One of the hallmark pathological characteristics of Alzheimer’s disease is the presence of neurofibrillary tangles containing hyperphosphorylated tau, a microtubule-associated protein. Therefore, we tested the hypothesis that insulin depletion caused by administration of streptozotocin may cause tau hyperphosphorylation in mouse brain by using site-specific phosphorylation-dependent tau antibodies to obtain precise identification of the phosphorylation of tau on individual residues. A massive (fivefold average increase) and widespread at multiple residues (detected with eight different phosphorylation-dependent tau antibodies) increase in the phosphorylation of tau was found in mouse cerebral cortex and hippocampus within 3 days of insulin depletion by streptozotocin treatment. This hyperphosphorylation of tau at some sites was rapidly reversible by peripheral insulin administration. Examination of several kinases that phosphorylate tau indicated that they were unlikely to account for the widespread hyperphosphorylation of tau caused by streptozotocin treatment, but there was a large decrease in mouse brain protein phosphatase 2A activity, which is known to mediate tau phosphorylation. These results show that insulin deficiency causes rapid and large increases in tau phosphorylation, a condition that could prime tau for the neuropathology of Alzheimer’s disease, thereby contributing to the increased susceptibility to Alzheimer’s disease caused by diabetes.

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				I. Vulih-Shultzman, A. Pinhasov, S. Mandel, N. Grigoriadis, O. Touloumi, Z. Pittel, and I. Gozes Activity-Dependent Neuroprotective Protein Snippet NAP Reduces Tau Hyperphosphorylation and Enhances Learning in a Novel Transgenic Mouse Model J. Pharmacol. Exp. Ther., November 1, 2007; 323(2): 438 - 449. [Abstract] [Full Text] [PDF]